Insider Transactions in Q3 2024 at Harmony Biosciences Holdings, Inc. (HRMY)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
23,643
-39.41%
|
$945,720
$40.0 P/Share
|
|
Sep 30
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
95,846
+50.0%
|
$1,150,152
$12.0 P/Share
|
|
Sep 30
2024
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
32,052
-53.42%
|
$1,282,080
$40.0 P/Share
|
|
Sep 30
2024
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+50.0%
|
-
|
|
Sep 30
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
35,846
-100.0%
|
$1,433,840
$40.03 P/Share
|
|
Sep 27
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
200
-100.0%
|
$8,000
$40.05 P/Share
|
|
Sep 27
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+50.0%
|
$4,800
$24.0 P/Share
|